Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program

Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317147121. doi: 10.1073/pnas.2317147121. Epub 2024 Feb 29.

Abstract

Mutations in genes encoding transcription factors inactivate or generate ectopic activities to instigate pathogenesis. By disrupting hematopoietic stem/progenitor cells, GATA2 germline variants create a bone marrow failure and leukemia predisposition, GATA2 deficiency syndrome, yet mechanisms underlying the complex phenotypic constellation are unresolved. We used a GATA2-deficient progenitor rescue system to analyze how genetic variation influences GATA2 functions. Pathogenic variants impaired, without abrogating, GATA2-dependent transcriptional regulation. Variants promoted eosinophil and repressed monocytic differentiation without regulating mast cell and erythroid differentiation. While GATA2 and T354M required the DNA-binding C-terminal zinc finger, T354M disproportionately required the N-terminal finger and N terminus. GATA2 and T354M activated a CCAAT/Enhancer Binding Protein-ε (C/EBPε) enhancer, creating a feedforward loop operating with the T-cell Acute Lymphocyte Leukemia-1 (TAL1) transcription factor. Elevating C/EBPε partially normalized hematopoietic defects of GATA2-deficient progenitors. Thus, pathogenic germline variation discriminatively spares or compromises transcription factor attributes, and retaining an obligate enhancer mechanism distorts a multilineage differentiation program.

Keywords: GATA; GATA2; differentiation; hematopoiesis; transcription.

MeSH terms

  • Cell Differentiation / genetics
  • GATA2 Transcription Factor / genetics
  • Genotype
  • Hematopoietic Stem Cells
  • Humans
  • Leukemia*
  • Regulatory Sequences, Nucleic Acid*

Substances

  • GATA2 protein, human
  • GATA2 Transcription Factor